Stoke Therapeutics
STOK
STOK
81 hedge funds and large institutions have $255M invested in Stoke Therapeutics in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 27 increasing their positions, 31 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
13% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 31
16% less funds holding
Funds holding: 96 → 81 (-15)
67% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 21
Holders
81
Holding in Top 10
2
Calls
$5K
Puts
$4K
Top Buyers
| 1 | +$20.1M | |
| 2 | +$6.64M | |
| 3 | +$6.56M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$2.86M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2.1M |
Top Sellers
| 1 | -$6.56M | |
| 2 | -$1.37M | |
| 3 | -$1.32M | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$1.29M |
| 5 |
BlackRock
New York
|
-$769K |